Tech Company Financing Transactions
SK Bioscience Funding Round
CEPI (Coalition for Epidemic Preparedness Innovations) participated in a $173.4 million capital raise for SK Bioscience. This venture round was announced on 5/25/2021.
Transaction Overview
Company Name
Announced On
5/25/2021
Transaction Type
Venture Equity
Amount
$173,400,000
Round
Undisclosed
Proceeds Purpose
The money will help pay for the clinical trials as well as scaling up vaccine manufacturing by SK bioscience, with the goal of annually producing hundreds of millions of doses.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
310 Panqyu-ro Bundang-gu
Seongnam-si Gyeonggi-do, 00000
South Korea
Seongnam-si Gyeonggi-do, 00000
South Korea
Phone
Website
Email Address
Not Recorded
Overview
SK bioscience is growing into a domestic and global vaccine developer by continuously making investments and establishing infrastructure for vaccine development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ahn Jae-yong
Browse more venture capital transactions:
Prev: 5/25/2021: Phaidra venture capital transaction
Next: 5/25/2021: Fireflies.ai venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs